Cargando…
Utility Assessment of Moderate to Severe Thyroid Eye Disease Health States
IMPORTANCE: Thyroid eye disease (TED) results in varying degrees of proptosis and diplopia negatively affecting quality of life (QoL), producing possibly substantial visual changes, disfigurement, and disability. OBJECTIVE: To determine the association of varying TED severities with QoL in a non-TED...
Autores principales: | Smith, Terry J., Cockerham, Kimberly, Lelli, Gary, Choudhary, Chitra, Taylor, Stephanie, Barretto, Naina, Enstone, Ashley, Oliver, Louisa, Lynch, Judah, Holt, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857514/ https://www.ncbi.nlm.nih.gov/pubmed/36580313 http://dx.doi.org/10.1001/jamaophthalmol.2022.3225 |
Ejemplares similares
-
SAT466 Inactive Thyroid Eye Disease Patient Journey
por: Cockerham, Kimberly, et al.
Publicado: (2023) -
SAT461 Hearing-related Issues Associated With Graves’ Disease, Thyroid Eye Disease And Treatment With Teprotumumab
por: Smith, Terry J, et al.
Publicado: (2023) -
PSAT261 Use of Steroids Pre- and Post-Teprotumumab in Thyroid Eye Disease Patients
por: Holt, Robert J, et al.
Publicado: (2022) -
RF35 | PSAT263 Efficacy of Teprotumumab for Thyroid Eye Disease in Hypothyroid Patients
por: Smith, Terry J, et al.
Publicado: (2022) -
Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
por: Cockerham, Kimberly P., et al.
Publicado: (2021)